An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Recruiting · NCT07033026 · Interventional (participants receive a specific treatment) · Lead sponsor: NGM Biopharmaceuticals, Inc
View the official record on ClinicalTrials.gov →Interventions studied
NGM120 Q4WNGM120 Q8WPlacebo given
What this trial is about
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Documented active diagnosis of colorectal cancer.
- Cachexia defined by Fearon criteria of weight loss.
- Signed informed consent.
Exclusion criteria
- Current active reversible causes of decreased food intake.
- Receiving tube feedings or parenteral nutrition at the time of Screening or Randomization.
- Have cachexia caused by other reasons.
Where it is running
28 locations listed across 8 US states.
- NGM Clinical Study Site - Los Angeles, California, United States
- NGM Clinical Study Site - Los Angeles, California, United States
- NGM Clinical Study Site - Santa Rosa, California, United States
- NGM Clinical Study Site - Margate, Florida, United States
- NGM Clinical Study Site - Baltimore, Maryland, United States
- NGM Clinical Study Site - New York, New York, United States
- NGM Clinical Study Site - Toledo, Ohio, United States
- NGM Clinical Study Site - Youngstown, Ohio, United States
- NGM Clinical Study Site - Dallas, Texas, United States
- NGM Clinical Study Site - Kingwood, Texas, United States
- NGM Clinical Study Site - Laredo, Texas, United States
- NGM Clinical Study Site - Richmond, Virginia, United States
- NGM Clinical Study Site - Appleton, Wisconsin, United States
- NGM Clinical Study Site - Goyang, South Korea
- NGM Clinical Study Site - Goyang, South Korea
- NGM Clinical Study Site - Incheon, South Korea
- NGM Clinical Study Site - Seoul, South Korea
- NGM Clinical Study Site - Seoul, South Korea
- NGM Clinical Study Site - Seoul, South Korea
- NGM Clinical Study Site - Suwon, South Korea
- NGM Clinical Study Site - Taichung, Taiwan
- NGM Clinical Study Site - Taipei, Taiwan
- NGM Clinical Study Site - Taoyuan, Taiwan
- NGM Clinical Study Site - Tbilisi, Georgia
- NGM Clinical Study Site - Tbilisi, Georgia
- NGM Clinical Study Site - Tbilisi, Georgia
- NGM Clinical Study Site - Tbilisi, Georgia
- NGM Clinical Study Site - Tbilisi, Georgia